How we are funded

PeptideClear is funded by referral fees from clinic, pharmacy, retailer, and brand partners. When a reader clicks through to a partner and completes a consultation, signup, or purchase, the partner pays us a one-off referral fee. The fee ranges from £20 to £150 per converted referral depending on the partner and the action.

What this means in practice

· You pay nothing to use PeptideClear.
· Information on the site is free and accessible without registration.
· When a partner pays us, the price you pay them is unchanged. The fee comes out of the partner\'s marketing budget, not from your pocket.
· We never share your data with a partner you have not chosen to click through to.
· We disclose referral relationships inline on every commercial page.

Categories of commercial relationship

High-touch GLP-1 clinics: Numan (published £100/£100 referral programme), Voy, Manual, Juniper. Referral fees are typically £80 to £150 per converted patient.
Low-touch GLP-1 pharmacies: Phlo, Pharmacy2U, SimplyMeds, Boots Online Doctor, Asda Online Doctor. Referral fees vary; some partners have active affiliate programs, others do not.
Research peptide retailers: my-peptides, Pure Peptides UK, Nooku, Direct Sarms, Aquila Peptides, Pinnacle Peptides. Where referral programs exist, they typically pay £15 to £40 per conversion.
Cosmetic peptide and collagen retailers: via Awin (Cult Beauty, LookFantastic, Boots, Holland and Barrett, Space NK) and direct brands (Bare Biology, Vital Proteins). Standard affiliate commission rates typically 5 to 15 percent.
UK longevity clinics: no UK longevity clinic currently runs an affiliate programme that we participate in. All longevity clinic editorial is unsponsored.

What we do not do

· We do not run third-party display advertising on the site.
· We do not sell your data to any partner or third party.
· We do not let referral fees decide which clinics, pharmacies, or retailers appear in rankings. Listing is gated by our published methodology, not by commercial terms.
· We do not write favourable copy in exchange for higher referral fees.
· We do not accept payment to remove negative editorial.
· We do not promote compounded GLP-1, grey-import medication, or unlicensed sources of POM medications regardless of partner offer.

Listed but not paid

Some UK clinics, pharmacies, retailers, and brands appear on the site without an active referral relationship. Inclusion is gated by our methodology, not by whether the partner pays. Where a partner has refused affiliate access (or where we have declined theirs because of regulatory or ethical concerns), we still list when the methodology floor is met.

Two examples

· At least two ranked research peptide retailers in 2026 do not run affiliate programmes we participate in. They are ranked on the same criteria as those that do.
· No UK longevity clinic currently has an affiliate relationship with PeptideClear. The full longevity clinic ranking is editorial-only.

Inline disclosure

Every commercial page on the site (where a click-through to a partner is the primary CTA) carries an inline affiliate disclosure adjacent to that CTA. This is more conservative than the ASA-required minimum, which is page-level disclosure. We use inline disclosure because it makes the commercial relationship visible at the decision point, not buried at the bottom of the page.

If a fee structure changes

Material changes to commercial relationships (a new partner added, an existing partner removed, a substantial change to the fee structure) are documented in editorial sign-off notes and visible to readers through the per-page "last reviewed" dates. We do not change a ranking position because a fee changes. We may add or remove a partner if regulatory status changes (loss of GPhC registration, MHRA enforcement action, etc).